SynOx Therapeutics
www.synoxtherapeutics.comSynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.
Read more
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.
Read more
Country
City (Headquarters)
Dublin
Industry
Employees
1-10
Founded
2020
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President of Quality
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chief Medical Officer
Email ****** @****.comPhone (***) ****-****Chief Technology Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(16)
Reach decision makers at SynOx Therapeutics
Free credits every month!
SynOx Therapeutics FAQ
Dublin, Ireland
Biotechnology Research
